ATS Q1 Earnings: 6.1% Revenue Growth Masked a Profit Squeeze and a 15% Orders Drop

ATS delivered revenue growth, but profitability and fresh orders weakened

ATS' first quarter looked healthy on the top line, but the rest of the result was less so. Revenue rose 6.1% to $736.7 million, while net income fell to $24.3 million from $35.3 million a year earlier and adjusted EBITDA slipped to $101.5 million from $106.0 million.

The demand signal was harder. Order Bookings were $693 million, 15.2% lower year over year, even as order backlog rose 9.9% to $2,068 million. In other words, the pipeline still supports near-term revenue, but new orders cooled.

Why the backlog still matters

Backlog growth means customers still have committed work for ATS to fulfill. The trailing twelve-month book-to-bill ratio remained healthy at 1.17, which suggests demand has not broken outright. Still, investors usually value a business on fresh demand, not just what is already in the pipeline.

Why the quarter still raised eyebrows

The reported growth was not coming mainly from the core business. Of the 6.1% year-over-year revenue increase, 4.1% was driven by acquisitions and 3.2% by favorable foreign exchange, while organic revenue declined 1.2%. At the same time, adjusted earnings from operations margin fell to 10.7% from 12.4%.

Revenue held the quarter together, but weaker orders and thinner margins were the more important signals.

The bigger question is whether ATS's growth is organic and durable

One weak quarter is not automatically a problem. The bigger issue is whether the business is converting revenue into profit more efficiently over time.

Acquisition and FX growth are easier to report than to repeat

Acquisitions can lift revenue quickly, but integration often creates short-term margin pressure as systems, processes, and teams are brought together. FX tailwinds can boost one quarter and reverse the next. That makes the key question simpler: how much of ATS's growth is repeatable from the underlying business?

Margin pressure kept the debate alive

Profitability did not improve alongside revenue. Revenues rose to $736.7 million, but net income fell to $24.3 million, adjusted EBITDA slipped to $101.5 million, and adjusted earnings from operations margin declined to 10.7% from 12.4%. More sales, by themselves, did not translate into more profit.

Diversification improved the backdrop, but it did not settle the case

The more encouraging part of the quarter was the end-market mix. Management described good diversification across our portfolio, and outside coverage pointed to a continued shift toward life sciences, food and beverage, and consumer products after earlier pain in EV-linked automation.

That matters because diversification can make a cyclical business more resilient. It does not, by itself, prove that organic demand is strong or that margins will recover. Investors still need to see whether a broader portfolio is producing better execution, not just a healthier-looking story.

What to watch in the next few quarters

The key question now is whether ATS can turn a still-solid backlog into cleaner execution.

A later quarter showed improvement, but durability is the point

ATS later delivered strong operational performance, with improved gross margin. That is encouraging, but the harder question is whether future gains are organic and repeatable rather than driven by mix, timing, or temporary cost control.

The signals that matter most

• Orders: Whether new bookings recover and keep the trailing book-to-bill healthy.
• Margins: Whether improvements spread from gross margin back through earnings and EBITDA.
• Growth quality: Whether revenue growth is increasingly organic rather than dependent on acquisitions or FX.
• Diversification: Whether the shift away from EV exposure is producing steadier demand across end markets.